KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Capital Expenditures: 2013-2024

Historic Capital Expenditures for Arbutus Biopharma (ABUS) over the last 12 years, with Dec 2024 value amounting to $86,000.

  • Arbutus Biopharma's Capital Expenditures was N/A to $86,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $214,000, marking a year-over-year change of. This contributed to the annual value of $182,000 for FY2024, which is 81.94% down from last year.
  • Latest data reveals that Arbutus Biopharma reported Capital Expenditures of $86,000 as of Q4 2024, which was up 8,500.00% from $1,000 recorded in Q2 2024.
  • Arbutus Biopharma's Capital Expenditures' 5-year high stood at $859,000 during Q2 2023, with a 5-year trough of $1,000 in Q2 2024.
  • In the last 3 years, Arbutus Biopharma's Capital Expenditures had a median value of $93,000 in 2022 and averaged $170,200.
  • As far as peak fluctuations go, Arbutus Biopharma's Capital Expenditures spiked by 857.58% in 2021, and later crashed by 99.88% in 2024.
  • Over the past 5 years, Arbutus Biopharma's Capital Expenditures (Quarterly) stood at $152,000 in 2020, then slumped by 61.84% to $58,000 in 2021, then skyrocketed by 131.03% to $134,000 in 2022, then tumbled by 64.84% to $32,000 in 2023, then crashed by 99.88% to $86,000 in 2024.
  • Its Capital Expenditures was $86,000 in Q4 2024, compared to $1,000 in Q2 2024 and $95,000 in Q1 2024.